Clinical Research Directory
Browse clinical research sites, groups, and studies.
MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study
Sponsor: Linkoeping University
Summary
The EPSOMIP2 (Evaluating the Prevalence and Severity Of MASLD In Primary care - a Follow-up Study) trial is a longitudinal cohort study of patients with type 2 diabetes recruited from primary health care centers in Östergötland, Sweden. Between 2019-2023, 317 patients were included and underwent rigorous clinical evaluation, vibration controlled transient elastography, biobanking of bloodsamples, and the latest magnetic resonance techniques to liver and body composition. All patients alive will be re-invited to undergo the same evaluation and additional tests.
Official title: Evaluating the Prevalence and Severity of MASLD in Primary Care - a Follow-up Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
317
Start Date
2025-12-16
Completion Date
2034-12-31
Last Updated
2025-12-31
Healthy Volunteers
No
Conditions
Locations (1)
Department of Gastroenterology and Hepatology, Linköping University Hospital
Linköping, Östergötland County, Sweden